USPTO serial 99908478
REGENERATIVE HEALTH WORLD CONGRESS
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- WHITE, TRAVIS WILLIAM
- Law office
- TMO LAW OFFICE 126
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with REGENERATIVE HEALTH WORLD CONGRESS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Wilmington, DE, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Megan Mischler
Megan Mischler Baker & Hostetler LLP1050 Connecticut Ave, N.W., Suite 1100Washington, DC 20036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Association services, namely, promoting the interests of clinicians and researches in the field of peptide medicine and therapeutics; Association services, namely, promoting public awareness of peptide medicine and therapeutics; association services, namely, promoting the study, training, and practice of peptide medicine and therapeutics; Association services, namely, promoting the public interest and awareness in peptide medicine and therapeutics research and education | ACTIVE | — |
| 041 | Educational services, namely, conducting educational courses in the field of peptide medicine and therapeutics; providing training for certification in the field of peptide medicine and therapeutics; arranging and conducting conferences in the field of peptide medicine and therapeutics | ACTIVE | — |
| 042 | Scientific research in the nature of conducting clinical trials for others in the field of peptide medicine and therapeutics; medical research | ACTIVE | — |
| 044 | Providing news and information in the field of peptide medicine and therapeutics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 26, 2026 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Oct 26, 2026 | IUAF | USE AMENDMENT FILED | — |
| Oct 26, 2026 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| Oct 26, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 24, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 26, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 26, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 26, 2026 | NWAP | NEW APPLICATION ENTERED | — |